Last Price
0.019
Today's Change
0.00 (0.00%)
Day's Change
0.019 - 0.02
Trading Volume
301,300
Overview
Market Cap
16 Million
Shares Outstanding
857 Million
Avg Volume
989,271
Avg Price (50 Days)
0.02
Avg Price (200 Days)
0.05
PE Ratio
-1.90
EPS
-0.01
Earnings Announcement
19-Feb-2025
Previous Close
0.02
Open
0.02
Day's Range
0.019 - 0.02
Year Range
0.016 - 0.12
Trading Volume
301,300
Price Change Highlight
1 Day Change
0.00%
5 Day Change
-5.00%
1 Month Change
0.00%
3 Month Change
-29.63%
6 Month Change
-67.24%
Ytd Change
-79.57%
1 Year Change
-81.90%
3 Year Change
-61.22%
5 Year Change
-71.64%
10 Year Change
-79.09%
Max Change
-95.13%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. Biotron Limited was incorporated in 1999 and is headquartered in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
CEO Morning Brief
Australia raised Fair Trade in Trump Phone Call, Says PM Albanese
2
CEO Morning Brief
Australia Faces Economic Pain From Trump Win, Treasurer Warns
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
